HEMOSTASIS COAGULATION RESEARCH INHIBITORS SYNTHETIC REVERSIBLE INHIBITORS
DAPA
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/congele.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/RUO.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/stockage_-70C.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/importateur.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/distributeur.jpg)
Formulation : Dansylarginin, N-(3-ethyl-1.5-pentanediyl)amid, HCl
C25H39O3N6SCl
MW(Da) : 539 Extinction coef. : 4010 Potent and specific synthetic thrombin inhibitor. (Ki=10-7M). Bound to thrombin, le fluorescence intensity increase 3 fold.
MW(Da) : 539 Extinction coef. : 4010 Potent and specific synthetic thrombin inhibitor. (Ki=10-7M). Bound to thrombin, le fluorescence intensity increase 3 fold.
![Cryopep](https://www.cryopep.fr/wp-content/uploads/resource/generated/thumbnail/Generique.jpg)
Reference | 9-DAPA |
---|---|
Presentation | Vial |
Format | 1 mg |
Quote |
Price list, safety data sheets and notices are accessible to our registered customers.
Reference | Presentation | Format | Quote | Product sheet |
---|---|---|---|---|
9-DAPA | Vial | 1 mg |